5 uncomfortable words i never thought i’d ever utter I AGREE WITH KARL ROVE

It's been a great week for three biotech innovators in the Adjuvant Capital portfolio. 😁😁😁 - Bill Gates announced $40 million of fresh funding for Univercells (lnkd.in/eP3jmSAg) - LimmaTech Biologics raised a $37 million Series A round co-led by Adjuvant, @AXAIMAlts, and

I'm biased, but this is a great story 😊... Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm - endpts.com/anti-microbial…

Proud to share that Adjuvant Capital's GBS-focused vaccine start-up (MinervaX) has added OrbiMed and EQT Group to its cap table. Pleased to welcome Tal Zaks and Vincent Brichard to the MinervaX board, overseeing a war chest of €125 million for a Phase III study. endpts.com/minervax-raise…

An LLM can code an iPhone app from scratch in 2 mins, but the House of Representatives still does business amongst its 435 members like my elementary school teachers calling roll from 20 students in the 1980s. Doing the people's business could be modernized in so many ways...

In addition to working on a major unmet need for kidney transplant patients (where there is currently no approved therapy for BKV), Memo Tx is also developing novel interventions for public health challenges such as Nipah virus and congenital CMV. Congrats on raising CHF 25mm!

Thanks to Rep. Brian Fitzpatrick 🇺🇸, Chrissy Houlahan, and María Elvira Salazar 🇺🇸 for introducing the Supporting Innovative Global Health Technologies (SIGHT) Act! The bill encourages USAID Global Health to move beyond siloes to embrace a disease-agnostic approach to #GlobalHealth R&D. fitzpatrick.house.gov/2023/11/fitzpa…

Much uncertainty ahead, but Rachel Presti presented initial data from Excision BioTherapeutics's ongoing Ph1 trial of a CRISPR-based attempt to cure HIV at ESGCT last month and it's been great to see so much interest in this. Nice write-up from MIT Technology Review. technologyreview.com/2023/10/25/108…

2023 was not a kind year for companies that invested heavily in the COVID-19 sphere, but Codagenix is still keeping on track with developing its vaccines for COVID-19 and other infectious diseases. #JPM2024 #JPM24 #JPMWeek #BioWeekSF #biospace hubs.li/Q02fPrv20

Congrats, Curevo Vaccine! Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head fiercebiotech.com/biotech/curevo…

Codagenix CEO, Paul Grint, MD, was interviewed for this WSJ Venture Capital feature by Brian Gormley about the recent uptick in #biotech acquisitions. Read here: wsj.com/articles/biote… #biopharma #innovation #healthcare

How Rachel Eguia, Carole Smith, and Leah Rommereim pursued careers in science, and what excites them most about their work at Variant Bio: medium.com/variantbio/ins…

Spot on, Brian Gormley and The Wall Street Journal: "Vaccine developers are facing an especially difficult venture financing market despite the success investors have had with Covid-19 vaccine developers Moderna and BioNTech..." wsj.com/articles/vacci… via The Wall Street Journal

Sacks Says: "People [Democrats] this hungry for power should never be entrusted with it." Sacks Does: qz.com/david-sacks-do…

I just took action with @theactionnet: Call Democratic Leadership: Biden Must Step Down. Take action here: actionnetwork.org/forms/call-dem…

Jesus seems like a real d*ck if he invested the effort necessary to save Donald Trump in this instance but meanwhile Jesus is super cool 😎 with American school children routinely dying in mass shootings.

Despicable. As families grieve, Trump should be leading, not lying. We put safety first, drove down close calls, grew Air Traffic Control, and had zero commercial airline crash fatalities out of millions of flights on our watch. President Trump now oversees the military and the